University Hospitals Birmingham NHS Foundation Trust

Status Drug name NICE TAs Comments Subchapter
Status: Red Edrophonium chloride 15.1
Status: Red Eliglustat (Cerdelga®)

NHSE commissioned

9.8
Status: Red Elosulfase lfa (Vimizim®)

NHSE commissioned

9.8
Status: Red Eltrombopag tablets 9.1
Status: Amber Eluxadoline (Truberzi®)

To be used in line with NICE TA 471. Specialist initiation, and transfer prescribing to GP using RICaD (in development).

1.5
Status: Green Empagliflozin 6.1
Status: Amber Empagliflozin (Jardiance®) 6.1
Status: Amber Empaglifozin 6.1
Status: Green Empaglifozin 6.1
Status: Green Emulsifying Ointment BP 13.2

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top